D G Shah, Founder Of Indian Pharmaceutical Alliance, Dies At Age 77: Economic Times22/02/2019 By William New, Intellectual Property Watch Leave a CommentDilip Shah, founder of the Indian Pharmaceutical Alliance (IPA) the organisation that represented the interests of Indian drug makers passed away in Mumbai on Friday. He was 77. Known in the industry as “DG”, Mr Shah started the IPA when the Indian pharma companies were trying to find their feet in the global pharma landscape that was dominated by the multinational pharma companies predominantly based out of Europe and USA. Shah who himself spent most of his career with the MNC drug companies …
Faced With Unreasonable Medicines Prices, The Netherlands Introduces Pharmacy Exemption In Patent Law22/02/2019 By Intellectual Property Watch Leave a CommentEllen ‘t Hoen writes: On 1 February 2019, article 53(3), second sentence of the Dutch Patent Act 1995 came into force introducing a patent exemption for the preparation of medicines in a pharmacy.
California Startup Brainbase Building Breakthrough Online IP Licensing Platform19/02/2019 By William New, Intellectual Property Watch 1 CommentBrainbase, a California tech startup with a team in Estonia, has received US$1M in seed funding to build an “end-to-end product ecosystem for intellectual property licensing” that could change the way businesses manage and licence their brands worldwide. The investment is an indication of dynamic evolution in the IP sector as it takes advantage of latest technologies and the talents of innovators.
WIPO Event: AI On All Fronts – Health, Cities, Agriculture – But Investment Needed; Europe Lagging12/02/2019 By Catherine Saez, Intellectual Property Watch 1 Comment
Pre-Grant Opposition Filed Against Janssen’s Bedaquiline Fumarate Application In India08/02/2019 By Intellectual Property Watch 2 Comments
WHO’s Access Roadmap And The Art Of Accommodation Of Pharma Interest26/01/2019 By Intellectual Property Watch 1 Comment
US Complaints About Technology Transfer In China: Negotiating The Endgame24/01/2019 By Intellectual Property Watch 1 Comment
US IP Law – Big Developments On The Horizon In 201923/01/2019 By Steven Seidenberg for Intellectual Property Watch Leave a Comment
EU Members Adopt Plan To Make Europe A Leader In Artificial Intelligence19/02/2019 By William New, Intellectual Property Watch Leave a Comment
ASEAN IP Offices Discuss Regional Trademark System18/02/2019 By William New, Intellectual Property Watch Leave a Comment
WTO IP Council: Praise For Public-Private Partnerships, Use Of Competition Law To Fight High Drug Prices18/02/2019 By Catherine Saez, Intellectual Property Watch Leave a Comment
Agreement On SPC Manufacturing Waiver Reached, Benefitting EU Generic, Biosimilar Industry14/02/2019 By David Branigan for Intellectual Property Watch 2 Comments
South Africa’s Copyright Amendment Bill Still Moving14/02/2019 By Linda Daniels for Intellectual Property Watch Leave a Comment
The Future Of The Ideas Business – The Rise Of Data-Driven Invention07/12/2018 By Intellectual Property Watch, Intellectual Property Watch 1 CommentNew ideas are getting harder to find, and with less ideas there is a decline in organisational productivity and economic growth. This isn’t new, nor is the fact that to counterbalance the decline in idea generation, research and development have received and continue to require heavy investment. But with daily news of innovation centres opening up across the globe, the question remains whether initiatives like open innovation, crowdsourcing, or simply putting more scientific brains together will do this investment justice. Last month, leading representatives of the IP, R&D and technology arenas met in Switzerland to discuss a technology-based alternative to human only idea generation. Hosted by data-driven invention company Iprova, the 2nd Data-Driven Invention Forum saw attendees from companies, such as Panasonic, Philips and DuPont as well as many other global organisations explore the future of innovation and the role data-driven invention plays in it. Here are some of the conclusions of the conference.
